title: Clinical value of a competitive NT-proBNP enzyme immunoassay compared to the Roche NT-proBNP platform.
authors.forename: Angelika
authors.initials: A
authors.lastname: Hammerer-Lercher
authors.forename: Andrea
authors.initials: A
authors.lastname: Griesmacher
authors.forename: Gerhard
authors.initials: G
authors.lastname: Pölzl
authors.forename: Natascha
authors.initials: N
authors.lastname: Brinskelle-Schmal
authors.forename: Johannes
authors.initials: J
authors.lastname: Mair
authors.forename: Matthias
authors.initials: M
authors.lastname: Frick
authors.forename: Gerhard
authors.initials: G
authors.lastname: Hawa
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D004345:Drug Industry; D005260:Female; D006333:Heart Failure / Q000097:blood; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods*; D008297:Male; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010446:Peptide Fragments / Q000097:blood*; D012372:ROC Curve; D055815:Young Adult
chemical_list: D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain